Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McQuay to head BSD's board

This article was originally published in Clinica

Executive Summary

BSD Medical’s board of directors has elected Timothy McQuay as chairman. Mr McQuay comes from an investment banking background, specialising in the healthcare industry. He is currently managing director of B Riley, of Los Angeles, California, and was previously at AG Edwards. Mr McQuay has served on BSD’s board since February 2008 as director and succeeds Paul Turner, who will continue to serve as a director. Salt Lake City, Utah-based BSD specialises in heat therapy for treating cancer.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel